HomeInsightsMarket Capitalization

Market Capitalization of Alembic Pharmaceuticals Ltd

Market Capitalization of Alembic Pharmaceuticals Ltd

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

3.0 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

Market Cap

₹ 20383.6 crore

Last updated on: Dec 26, 2024

Key Highlights

  • The Market Cap of Alembic Pharmaceuticals Ltd is ₹ 20383 crore as of 26 Dec 24 .
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10000 crore on March 2019 to ₹ 19309 crore on March 2024 . This represents a CAGR of 11.59% over 6 years.
  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 1037 as of 26 Dec 15:30 .
  • The dividend payouts of Alembic Pharmaceuticals Ltd changed from ₹ 7 to ₹ 11 over 6 quarters. This represents a CAGR of 35.16% .

Historical Market Cap of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Alembic Pharmaceuticals Ltd

No data available

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

Share Price

₹ 1037

0.70 (0.07%)

stock direction

Last updated on: Dec 26, 2024

Market Price of Alembic Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20241037
24 Dec 20241036.3
23 Dec 20241044.6
20 Dec 20241055
19 Dec 20241050.15
18 Dec 20241056
17 Dec 20241035.75
16 Dec 20241054.6
13 Dec 20241061.35
12 Dec 20241046.45

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Alembic Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Alembic Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Alembic Pharmaceuticals Ltd

No data available

* All values are in

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
  • As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharmaceuticals receives USFDA approval for Divalproex Sodium

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

Read more

20 Dec 2024 18:30

News

Alembic Pharma gets USFDA nod for seizure treatment drug

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

20 Dec 2024 14:20

News

Alembic Pharma Panelav unit clears Brazil GMP audit

Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency ...

Read more

11 Dec 2024 12:39

News

Alembic Pharma receives USFDA's tentative approval for Olopatadine Hydrochloride Ophthalmic Solution

Alembic Pharmaceuticals announced that it has received Tentative Approval from the US Food...

Read more

04 Dec 2024 16:41

News

Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride eye drops

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

04 Dec 2024 14:54

News

Alembic Pharma Gujarat facility gets 5 observations from USFDA

The GMP inspection was conducted from 14 November 2024 to 22 November 2024. The USFDA issu...

Read more

25 Nov 2024 11:19

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Alembic Pharmaceuticals Ltd Market Cap

What is the market cap of Alembic Pharmaceuticals Ltd?

As of December 26, 2024, Alembic Pharmaceuticals Ltd has a market capitalization of ₹20383.6, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Alembic Pharmaceuticals Ltd's market capitalization?

Alembic Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Alembic Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Alembic Pharmaceuticals Ltd's market capitalization change?

Alembic Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions